October 7, 2016—The Medicare Payment Advisory Commission continues to look at ways to put a lid on rising drug costs. MedPAC, which advises Congress on Medicare policy, has been meeting this week to continue discussions that began last year on changing how Medicare pays providers for drugs. MedPAC plans to make recommendations this spring. Reducing payment rates to hospitals in the 340B drug discount program should be off the table.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)